Search

everythinglearnresearchcommunity

for

Search:↓

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Different γδ T cell types have unique roles in causing alopecia areata.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Dandruff can affect confidence and should be treated with proper shampoos or medical advice.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Early regulatory T cells are crucial for normal skin pigmentation.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata involves unique activation of certain immune cells.